Validation of Tissue Microarray Technology in Breast Carcinoma
Top Cited Papers
Open Access
- 1 December 2000
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 80 (12), 1943-1949
- https://doi.org/10.1038/labinvest.3780204
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinomaCancer, 1999
- Hormone Therapy Failure in Human Prostate Cancer: Analysis by Complementary DNA and Tissue MicroarraysJNCI Journal of the National Cancer Institute, 1999
- High-Throughput Tissue Microarray Analysis to Evaluate Genes Uncovered by cDNA Microarray Screening in Renal Cell CarcinomaThe American Journal of Pathology, 1999
- Tissue Heterogeneity of Immunohistochemically Detected Estrogen Receptor: Implications for Image Analysis QuantificationAmerican Journal of Clinical Pathology, 1998
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Expression of c-met is a strong independent prognostic factor in breast carcinomaCancer, 1998
- Immunoperoxidase staining for estrogen and progesterone receptors in archival formalin fixed, paraffin embedded breast carcinomas after microwave antigen retrieval.Biotechnic & Histochemistry, 1997
- Loss of Tumor Marker-Immunostaining Intensity on Stored Paraffin Slides of Breast CancerJNCI Journal of the National Cancer Institute, 1996
- Expression of the CD15 antigen (Lewis x) in breast cancerJournal of Molecular Histology, 1995
- The variability of estrogen receptors in metastatic breast cancerThe American Journal of Surgery, 1979